Diuretics
DR.IBRAHIM HASSAAN,MBCHB,MSC,EDAIC
11/06/2023
diuretic drugs exert their effects On nephron
Mannitol
MOA
> Mannitol is a sugar alcohol solution, which works as an osmotic diuretic.
> The drug is freely filtered by the glomerulus but not reabsorbed.
> It increases the osmolality of the filtrate and so water follows the drug to be excreted.
> Osmotic activity occurs mainly at proximal convoluted tubule and loop of Henle
DOSE
0.5–1 g/kg IV bolus over 20 min
EFFECTS
CVS ---Initial ↑ in circulating volume – take care in patients with CCF
CNS ----↓ ICP
Indicated in the treatment of raised ICP BY
Decreasing the formation of CSF.
Decreasing plasma volume and thereby encouraging water to move out of the brain,reducing
edema.
Mannitol does not cross the intact blood–brain barrier.
It is free radical scavenger and so may afford some additional neuroprotection.
Spironolactone
USES:
Ascites
Nephrotic syndrome
Conn’s syndrome (primary hyperaldosteronism)
MOA
◦ Acts at distal convoluted tubule and collecting
ducts
◦ Competitive antagonist of aldosterone
◦ Aldosterone stimulates reabsorbtion of Na+ in
exchange for K+
Kinetics:
ABSORPTION
Oral bioavailability > 70%
DISTRIBUTION
Protein binding 90%
METABOLISM
hepatic
EXCRETION
urine

Diuretics.pptx

  • 1.
  • 2.
    diuretic drugs exerttheir effects On nephron
  • 4.
    Mannitol MOA > Mannitol isa sugar alcohol solution, which works as an osmotic diuretic. > The drug is freely filtered by the glomerulus but not reabsorbed. > It increases the osmolality of the filtrate and so water follows the drug to be excreted. > Osmotic activity occurs mainly at proximal convoluted tubule and loop of Henle DOSE 0.5–1 g/kg IV bolus over 20 min EFFECTS CVS ---Initial ↑ in circulating volume – take care in patients with CCF CNS ----↓ ICP
  • 5.
    Indicated in thetreatment of raised ICP BY Decreasing the formation of CSF. Decreasing plasma volume and thereby encouraging water to move out of the brain,reducing edema. Mannitol does not cross the intact blood–brain barrier. It is free radical scavenger and so may afford some additional neuroprotection.
  • 6.
    Spironolactone USES: Ascites Nephrotic syndrome Conn’s syndrome(primary hyperaldosteronism) MOA ◦ Acts at distal convoluted tubule and collecting ducts ◦ Competitive antagonist of aldosterone ◦ Aldosterone stimulates reabsorbtion of Na+ in exchange for K+ Kinetics: ABSORPTION Oral bioavailability > 70% DISTRIBUTION Protein binding 90% METABOLISM hepatic EXCRETION urine